EASY BIO,Inc. (353810.KQ)

KRW 4570.0

(0.44%)

Operating Expenses Summary of EASY BIO,Inc.

  • EASY BIO,Inc.'s latest annual operating expenses in 2023 was 29.67 Billion KRW , down -2.81% from previous year.
  • EASY BIO,Inc.'s latest quarterly operating expenses in 2024 Q2 was 18.76 Billion KRW , up 52.86% from previous quarter.
  • EASY BIO,Inc. reported a annual operating expenses of 31.13 Billion KRW in annual operating expenses 2022, up 30.52% from previous year.
  • EASY BIO,Inc. reported a annual operating expenses of 23.85 Billion KRW in annual operating expenses 2021, up 64.89% from previous year.
  • EASY BIO,Inc. reported a quarterly operating expenses of 11.68 Billion KRW for 2024 Q1, up 40.35% from previous quarter.
  • EASY BIO,Inc. reported a quarterly operating expenses of 6.95 Billion KRW for 2023 Q1, down -6.27% from previous quarter.

Annual Operating Expenses Chart of EASY BIO,Inc. (2023 - 2020)

Historical Annual Operating Expenses of EASY BIO,Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 29.67 Billion KRW -2.81%
2022 31.13 Billion KRW 30.52%
2021 23.85 Billion KRW 64.89%
2020 14.46 Billion KRW 0.0%

Peer Operating Expenses Comparison of EASY BIO,Inc.

Name Operating Expenses Operating Expenses Difference
HLB Co., Ltd. 109.98 Billion KRW 73.022%
iNtRON Biotechnology, Inc. 7.84 Billion KRW -278.188%
BINEX Co., Ltd. 55.67 Billion KRW 46.706%
Bioneer Corporation 204.55 Billion KRW 85.495%
Anterogen.Co.,Ltd. 7.74 Billion KRW -283.349%
MEDIPOST Co., Ltd. 65.31 Billion KRW 54.571%
CrystalGenomics, Inc. 32.36 Billion KRW 8.335%
Helixmith Co., Ltd 37.36 Billion KRW 20.594%
Chabiotech Co.,Ltd. 285.93 Billion KRW 89.623%
Medy-Tox Inc. 110.88 Billion KRW 73.241%
Peptron, Inc. 16.65 Billion KRW -78.14%
Amicogen, Inc. 52.82 Billion KRW 43.828%
Genexine, Inc. 41.62 Billion KRW 28.722%
HLB Therapeutics Co.,Ltd. 16.16 Billion KRW -83.54%
LegoChem Biosciences, Inc. 98.61 Billion KRW 69.913%
ALTEOGEN Inc. 40.93 Billion KRW 27.515%
PharmaResearch Co., Ltd. 89.44 Billion KRW 66.825%
SillaJen, Inc. 5.11 Billion KRW -480.409%
JETEMA, Co., Ltd. 25.66 Billion KRW -15.615%
OliX Pharmaceuticals,Inc 35.24 Billion KRW 15.823%
Genomictree Inc. 16.26 Billion KRW -82.43%
MedPacto, Inc. 26.91 Billion KRW -10.225%
D&D Pharmatech 32.16 Billion KRW 7.746%
GI Innovation, Inc. 57.59 Billion KRW 48.48%